Please Wait

Applying Filters...

5 FU Medac
CEP/COS
Table View

Molecular glue degraders: Lilly, AbbVie sign billion-dollar deals; BMS leads with three late-stage drugs

Data Compilation
#PharmaFlow

Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

Stock Recap
#PipelineProspector

5 FU medac

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

31 API Suppliers, 15 USDMF, 4 CEP/COS, 2 JDMF, 14 NDC API, 15 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

103 Drugs in Development

103 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

170 FDF Dossiers, 69 FDA Orange Book, 42 Europe, 6 Canada, 28 Australia, 11 South Africa, 14 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;TOPICAL - 2%, SOLUTION;TOPICAL - 5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;TOPICAL - 0.5%, CREAM;TOPICAL - 4%

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 SPI Pharma, 10 DKSH, 6 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 5 Actylis, 10 BASF, 1 BioSpectra, 1 Clariant, 2 Corel Pharma Chem, 2 Finar, 6 Gangwal Chemicals, 7 Kerry, 2 Lubrizol Life Science Health, 3 Microlex e.U, 2 Nanjing Bold Chemical, 1 Pluviaendo, 4 Roquette, 9 Seppic, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

28 Topical, 22 Solubilizers, 15 Parenteral, 11 Film Formers & Plasticizers, 10 Emulsifying Agents, 10 Thickeners and Stabilizers, 10 Fillers, Diluents & Binders, 9 Coating Systems & Additives, 7 Surfactant & Foaming Agents, 6 Co-Processed Excipients, 4 Direct Compression, 4 Lubricants & Glidants, 3 Rheology Modifiers, 2 Granulation, 2 Controlled & Modified Release, 1 API Stability Enhancers

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 40 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 46 Regulatory FDF Prices, 1 Annual Reports

MARKET PLACE

15 APIs, 15 FDF Dossiers

REF. STANDARDS & IMPURITIES

6 EDQM, 5 USP, 6 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls download

Filters

Log in to access your PharmaMiles and download the data

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
28/03/2025	IMCD Group	Netherlands	IMCD SWITZERLAND AG Zürich CH	R1-CEP 2000-092 - Rev 07	Fluorouracil, Micronised, non-micronised	2021-07-16	Valid	Chemical		611
28/03/2025	NANTONG HAIERS PHARMACEUTICAL CO., LTD. CN 226400 Rudong	China	NANTONG HAIERS PHARMACEUTICAL CO., LTD. Nantong CN	R1-CEP 2008-183 - Rev 00	Fluorouracil	2014-10-31	Withdrawn by EDQM Failure to CEP procedure	Chemical	2015-03-30	611

Contact us
to update this info

5 FU Medac

5 FU medac

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

31 API Suppliers

15 USDMF

4 CEP/COS

2 JDMF

14 NDC API

15 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

103 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

170 FDF Dossiers

69 FDA Orange Book

42 Europe

6 Canada

28 Australia

11 South Africa

14 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;TOPICAL - 2%

SOLUTION;TOPICAL - 5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CREAM;TOPICAL - 0.5%

CREAM;TOPICAL - 4%

RELATED EXCIPIENT COMPANIES

2 EUROAPI

1 SPI Pharma

10 DKSH

6 Nanjing Well Pharmaceutical

1 Pfanstiehl

5 Actylis

10 BASF

1 BioSpectra

1 Clariant

2 Corel Pharma Chem

2 Finar

6 Gangwal Chemicals

7 Kerry

2 Lubrizol Life Science Health

3 Microlex e.U

2 Nanjing Bold Chemical

1 Pluviaendo

4 Roquette

9 Seppic

1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

28 Topical

22 Solubilizers

15 Parenteral

11 Film Formers & Plasticizers

10 Emulsifying Agents

10 Thickeners and Stabilizers

10 Fillers, Diluents & Binders

9 Coating Systems & Additives

7 Surfactant & Foaming Agents

6 Co-Processed Excipients

4 Direct Compression

4 Lubricants & Glidants

3 Rheology Modifiers

2 Granulation

2 Controlled & Modified Release

1 API Stability Enhancers

DIGITAL CONTENT

1 Data Compilation #PharmaFlow

40 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions

46 Regulatory FDF Prices

1 Annual Reports

MARKET PLACE

15 APIs

15 FDF Dossiers

REF. STANDARDS & IMPURITIES

SOLUTION;TOPICAL - 5% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons